Study finds increased cancer risk with bone growth product
Friday, November 4, 2011 - 15:31
in Health & Medicine
Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years after being implanted with the product, according to a new analysis.